Brief: Tempus And Medtronic Announce Alert Trial Results Showing Ai-Driven Ehr Notifications Improve Treatment For Significant Valvular Heart Disease
April 1 (Reuters) - Tempus AI Inc TEM.O: TEMPUS AND MEDTRONIC ANNOUNCE ALERT TRIAL RESULTS SHOWING AI-DRIVEN EHR NOTIFICATIONS IMPROVE TREATMENT FOR SIGNIFICANT VALVULAR HEART DISEASE TEMPUS AI INC: STUDY MET ITS PRIMARY ENDPOINT, DEMONSTRATING THAT AUTOMATED ECN ALERTS WERE SUPERIOR TO USUAL CARE IN A WIN RATIO ANALYSIS Source text: ID:nBw30MBkCa Further company coverage: TEM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempus AI
See all newsU.S. STOCKS ON THE MOVE-Tempus AI, Choice Hotels, Palantir
Tempus AI rises after surprise quarterly profit
Tempus AI Q3 revenue slightly beats estimates; raises guidance
Brief: Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling
Brief: Tempus Expands Strategic Collaboration With Bristol Myers Squibb